These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21559673)

  • 1. Molecular markers as intermediate end-points in chemoprevention of colon-cancer - modulation of ras activation by sulindac and phenylhexylisothiocyanate during colon carcinogenesis.
    Singh J; Rao C; Kulkarni N; Simi B; Reddy B
    Int J Oncol; 1994 Nov; 5(5):1009-18. PubMed ID: 21559673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis.
    Singh J; Kulkarni N; Kelloff G; Reddy BS
    Carcinogenesis; 1994 Jul; 15(7):1317-23. PubMed ID: 8033306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chemopreventive agents on posttranslational plasmamembrane association of ras-p21 during chemoprevention of azoxymethane-induced colon carcinogenesis.
    Singh J; Reddy B
    Int J Oncol; 1995 Feb; 6(2):301-6. PubMed ID: 21556537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
    Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate biomarkers of colon cancer: modulation of expression of ras oncogene by chemopreventive agents during azoxymethane induced colon carcinogenesis.
    Singh J; Kelloff G; Reddy BS
    Carcinogenesis; 1993 Apr; 14(4):699-704. PubMed ID: 8472334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of alterations in p53 tumor suppressor gene and its association with activation of ras proto-oncogenes during chemoprevention of colon cancer.
    Singh J; Kelloff G; Reddy B
    Int J Oncol; 1997 Mar; 10(3):449-56. PubMed ID: 21533396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Mutated
    Rice PFS; Ehrichs KG; Jones MS; Chen H; Hsu CH; Abril ER; Nagle RB; Besselsen DG; Barton JK; Ignatenko NA
    Cancer Prev Res (Phila); 2018 Jan; 11(1):16-26. PubMed ID: 29118162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis.
    Singh J; Rivenson A; Tomita M; Shimamura S; Ishibashi N; Reddy BS
    Carcinogenesis; 1997 Apr; 18(4):833-41. PubMed ID: 9111222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis.
    Singh J; Kelloff G; Reddy BS
    Cancer Epidemiol Biomarkers Prev; 1992; 1(5):405-11. PubMed ID: 1305473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Aug; 57(16):3465-70. PubMed ID: 9270014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
    Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS
    Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of colon carcinogenesis by organosulfur compounds.
    Reddy BS; Rao CV; Rivenson A; Kelloff G
    Cancer Res; 1993 Aug; 53(15):3493-8. PubMed ID: 8339252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
    Tanaka T; Kojima T; Suzui M; Mori H
    Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.
    Khare S; Cerda S; Wali RK; von Lintig FC; Tretiakova M; Joseph L; Stoiber D; Cohen G; Nimmagadda K; Hart J; Sitrin MD; Boss GR; Bissonnette M
    Cancer Res; 2003 Jul; 63(13):3517-23. PubMed ID: 12839936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of experimental colon carcinogenesis by dietary 6-phenylhexyl isothiocyanate.
    Rao CV; Rivenson A; Simi B; Zang E; Hamid R; Kelloff GJ; Steele V; Reddy BS
    Cancer Res; 1995 Oct; 55(19):4311-8. PubMed ID: 7671241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
    Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
    Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
    Janakiram NB; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.